- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
HSAs grow despite uncertainties
The Consumer Driven Healthcare Institute?s (CDHCI) quarterly report, ?The Consumer Driven Healthcare (CDHC) Market Data Advisory,? aggregates blind data from millions of actual health savings accounts (HSAs) provided by CDHCI members and partners.
The Consumer Driven Healthcare Institute’s (CDHCI) quarterly report, “The Consumer Driven Healthcare (CDHC) Market Data Advisory,” aggregates blind data from millions of actual health savings accounts (HSAs) provided by CDHCI members and partners. According to the report, total accounts administered in HSA programs on average grew 4% in the first quarter of 2010.
The growth comes amid questions raised by the Patient Protection and Affordable Care Act (PPACA), and how its implementation will affect consumer-driven healthcare.
“Under the PPACA, we anticipate that state health insurance exchanges will allow for inclusion of consumer driven account-based plans that meet the standards prescribed under the law,” says David Randall, executive director of CDHCI in Washington, D.C. “As an example, the Massachusetts Health Connector allows high-deductible health plans to be included as a plan option that employers and individuals can choose from. Further, we expect that consumer driven healthcare will continue to grow as more employers seek these plans as a means of controlling health care costs.”
Additional findings from the report showed employers on average contributed $200 each month into individual HSAs and $238 into family HSAs. Employees, on average, contributed $188 each month into individual HSAs, and $387 into family HSAs.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
FDA Site Inspections Decreased During Pandemic. Questions Continue about Drug Quality.
December 4th 2023A recent study has found that FDA inspections of drug manufacturing facilities have increased since the COVID-19 health emergency but have not yet returned to pre-pandemic numbers.
Read More
